ReviewAnnals of medicine and surgery (2012)2025
Public-private partnerships in tackling sickle cell disease in Uganda: a narrative review.
Review in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- From policy to practice: World Health Organization's contribution to safer blood transfusions in Africa for sickle cell management - a review.Annals of medicine and surgery (2012) · 2026Review
- "Heartbreak and Frustration'' experiences of healthcare providers caring for pregnant women with sickle cell disease in Uganda.PloS one · 2026Article
- Innovative hematological strategies to combat maternal and child mortality in Africa: focus on anemia and sickle cell disease.Annals of medicine and surgery (2012) · 2026Review
- Coagulation abnormalities in pediatric anemia clinical and laboratory correlates for risk stratification and risk assessment.Annals of medicine and surgery (2012) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sickle cell disease (SCD) remains a critical public health challenge in Uganda, where the prevalence is among the highest globally, and particularly affecting children. The management of SCD is complicated by limited healthcare infrastructure, a shortage of trained healthcare professionals, and widespread stigmatization. Public-private partnerships (PPPs) have emerged as a strategic solution to these challenges, leveraging the strengths of both the public and private sectors to improve access to care, enhance patient outcomes, and raise public awareness. This narrative review examines the role of PPPs in tackling SCD in Uganda, focusing on key areas such as health infrastructure development, capacity building for healthcare workers, and access to essential medications and treatments. The review highlights successful models of PPPs that have facilitated the establishment of specialized sickle cell clinics, the implementation of cost-effective screening programs, and community engagement initiatives aimed at reducing stigma and promoting early diagnosis. These partnerships have significantly contributed to improving the quality of care for individuals with SCD, particularly in high-prevalence regions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.